Ottobock SE KGaA (OBCK) Stock Overview

Designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. More details

OBCK fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	5/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 67.5% below our estimate of its fair value

Earnings grew by 46.1% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

OBCK Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Ottobock SE & Co. KGaA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ottobock SE KGaA
Historical stock prices
Current Share Price	€64.15
52 Week High	€73.00
52 Week Low	€63.55
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-8.68%

Recent updates

Shareholder Returns

	OBCK	DE Medical Equipment	DE Market
7D	-3.5%	3.7%	0.2%
1Y	n/a	-6.2%	12.5%

Return vs Industry: Insufficient data to determine how OBCK performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how OBCK performed against the German Market.

Price Volatility

Is OBCK's price volatile compared to industry and market?
OBCK volatility
OBCK Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.7%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	12.2%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: OBCK's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine OBCK's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1919	9,279	Oliver Jakobi	corporate.ottobock.com/en/home

Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closure systems; temporary fittings for after accidents and injuries; ankle sprains products; fittings for partial paralysis of legs; and mechatronic orthosis systems. It also offers mobility solutions, such as manual and power wheelchairs and rehabilitation products that includes standing supports, seating systems, and seat cushions for active and athletic users.

Ottobock SE & Co. KGaA Fundamentals Summary

How do Ottobock SE KGaA's earnings and revenue compare to its market cap?
OBCK fundamental statistics
Market cap	€4.11b
Earnings (TTM)	€57.90m
Revenue (TTM)	€1.64b

71.0x

P/E Ratio

2.5x

P/S Ratio

Is OBCK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OBCK income statement (TTM)
Revenue	€1.64b
Cost of Revenue	€781.50m
Gross Profit	€860.90m
Other Expenses	€803.00m
Earnings	€57.90m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 13, 2025

Earnings per share (EPS)	0.90
Gross Margin	52.42%
Net Profit Margin	3.53%
Debt/Equity Ratio	448.3%

How did OBCK perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/21 21:00
End of Day Share Price	2025/10/20 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ottobock SE & Co. KGaA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Ottobock SE & Co. KGaADB:OBCK Stock Report